secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001437749-25-031674
Event type: litigation
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Federal court dismisses criminal indictment against Cassava's former collaborator Dr. Wang
--------------------------------------------------------------------------------

- U.S. District Court for Maryland granted unopposed motion to dismiss with prejudice all charges against Dr. Hoau-Yan Wang.
- Charges had accused Dr. Wang of causing false grant applications and fabricating research results including Western Blot images.
- Dismissal permanently terminates the case; no future charges can be refiled.
- Company reaffirms its simufilam program for TSC-related epilepsy based on research at multiple institutions.
- Cassava states support for integrity in scientific research and distances from the dismissed allegations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925031674/0001437749-25-031674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925031674/sava20251024_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer